• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

氯尼达明对小鼠Meth-A纤维肉瘤的放射增敏作用

Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine.

作者信息

Kim J H, Alfieri A, Kim S H, Young C W, Silvestrini B

出版信息

Oncology. 1984;41 Suppl 1:36-8. doi: 10.1159/000225883.

DOI:10.1159/000225883
PMID:6717893
Abstract

Isogenic male BALB/c mice bearing Meth-A tumors in the ascites form were used. The effects of Lonidamine and irradiation both alone and in combination were studied. Lonidamine administered intraperitoneally produced a significant enhancement of irradiation effects.

摘要

使用了携带腹水型Meth-A肿瘤的同基因雄性BALB/c小鼠。研究了氯尼达明和辐照单独及联合使用的效果。腹腔注射氯尼达明可显著增强辐照效果。

相似文献

1
Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine.氯尼达明对小鼠Meth-A纤维肉瘤的放射增敏作用
Oncology. 1984;41 Suppl 1:36-8. doi: 10.1159/000225883.
2
Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.氯尼达明：培养的HeLa细胞及体内Meth-A肿瘤的热增敏剂。
Oncology. 1984;41 Suppl 1:30-5. doi: 10.1159/000225882.
3
Potentiation of radiation effects on two murine tumors by lonidamine.氯尼达明对两种小鼠肿瘤辐射效应的增强作用。
Cancer Res. 1986 Mar;46(3):1120-3.
4
Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene-induced fibrosarcoma (Meth A) in ascites form by Aloctin A.一种植物凝集素Aloctin A的药理学研究。I. Aloctin A对小鼠甲基胆蒽诱导的腹水型纤维肉瘤（Meth A）的生长抑制作用。
Experientia. 1981 Nov 15;37(11):1186-7. doi: 10.1007/BF01989910.
5
Lonidamine and radiotherapy in head and neck cancers. A pilot study.氯尼达明与头颈癌放疗：一项初步研究
Oncology. 1984;41 Suppl 1:113-5. doi: 10.1159/000225898.
6
Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
Oncology. 1984;41 Suppl 1:94-103. doi: 10.1159/000225895.
7
Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.联合治疗：氯尼达明、热疗与化疗对体内RIF-1肿瘤的作用
Cancer Res. 1991 Nov 1;51(21):5910-4.
8
Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.氯尼达明单独及与其他化疗药物联合用于癌症患者的治疗。
Oncology. 1984;41 Suppl 1:108-12. doi: 10.1159/000225897.
9
Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.
Oncology. 1984;41 Suppl 1:116-20. doi: 10.1159/000225899.
10
Potentiation of radiation effects on multicellular tumor spheroids (MTS) of HeLa cells by lonidamine.
Int J Radiat Oncol Biol Phys. 1989 May;16(5):1277-80. doi: 10.1016/0360-3016(89)90298-8.

引用本文的文献

1
Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.氯尼达明诱导前列腺癌异种移植瘤的选择性酸化和去能化：增强肿瘤对放射治疗的反应。
Cancers (Basel). 2024 Mar 31;16(7):1384. doi: 10.3390/cancers16071384.
2
pH-dependent structural characteristics of lonidamine: H and C NMR study.氯尼达明的pH依赖性结构特征：氢和碳核磁共振研究
RSC Adv. 2023 Jul 3;13(29):19813-19816. doi: 10.1039/d3ra01615c. eCollection 2023 Jun 29.
3
Tumoral oxygenation and biodistribution of Lonidamine oxygen microbubbles following localized ultrasound-triggered delivery.
瘤内氧合及超声触发局部给药后洛尼达明氧微泡的生物分布。
Int J Pharm. 2022 Sep 25;625:122072. doi: 10.1016/j.ijpharm.2022.122072. Epub 2022 Aug 3.
4
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.黑色素瘤模型代谢活性差异对洛尼达明联合多柔比星反应的影响。
Sci Rep. 2018 Oct 2;8(1):14654. doi: 10.1038/s41598-018-33019-4.
5
Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide.氯尼达明对替莫唑胺全身治疗DB-1人黑色素瘤异种移植瘤的影响。
Anticancer Res. 2017 Jul;37(7):3413-3421. doi: 10.21873/anticanres.11708.
6
Mechanism of antineoplastic activity of lonidamine.氯尼达明的抗肿瘤活性机制。
Biochim Biophys Acta. 2016 Dec;1866(2):151-162. doi: 10.1016/j.bbcan.2016.08.001. Epub 2016 Aug 4.
7
The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.抗肿瘤药物氯尼达明是线粒体丙酮酸载体和质膜单羧酸转运体的强效抑制剂。
Biochem J. 2016 Apr 1;473(7):929-36. doi: 10.1042/BJ20151120. Epub 2016 Feb 1.
8
Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.氯尼达明可诱导乳腺癌、前列腺癌和卵巢癌异种移植瘤细胞内肿瘤酸化及ATP耗竭，并增强对多柔比星的反应。
NMR Biomed. 2015 Mar;28(3):281-90. doi: 10.1002/nbm.3240. Epub 2014 Dec 12.
9
Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.洛尼达明在9L脑肿瘤模型中的作用机制涉及抑制乳酸外流和细胞内酸化。
J Neurooncol. 1998 Jan;36(2):149-57. doi: 10.1023/a:1005819604858.
10
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.新生霉素、拓扑替康和氯尼达明对抗肿瘤烷化剂的调节作用。
Cancer Chemother Pharmacol. 1993;32(6):455-62. doi: 10.1007/BF00685890.